Browser-side verification
Verify Piroxicam
คุณไม่ต้องเชื่อ source.cuvetsmo.com — โค้ดด้านล่างทำงานในเครื่องของคุณ คำนวณ SHA-256 และ verify Ed25519 signature เทียบกับ public key ที่อาจารย์เซ็นต์รับเก็บไว้.
Signatures
0
Version
1
Status
pending
⏳ ยังไม่มี signature
Entry นี้ยังไม่ได้ลงนามโดย key ใดเลย — Phase 0 mirror snapshot ที่รอ Thai translation + faculty signoff. ดูสถานะการ review ที่ หน้า detail
Show the raw inputs (paranoid mode)
Drug JSON
This is exactly what your browser canonicalizes + SHA-256-hashes
{
"slug": "piroxicam",
"nameEn": "Piroxicam",
"nameTh": "ไพร็อกซิแคม",
"class": "NSAID — oxicam derivative (notable antitumor use)",
"mechanism": "ยากลุ่ม NSAID ชนิด oxicam ยับยั้ง COX แบบ nonselective; มี enterohepatic recycling ทำให้ครึ่งชีวิตยาว; นอกจากฤทธิ์ต้านการอักเสบ มีฤทธิ์ต้านมะเร็ง (antitumor) ที่น่าสนใจในสุนัข",
"brandNamesTh": [
"Feldene"
],
"indications": [
{
"text": "สุนัข — ใช้เป็น adjunct ในมะเร็ง โดยเฉพาะ transitional cell carcinoma (TCC) ของกระเพาะปัสสาวะ ที่มีรายงานช่วยลดขนาดก้อนเนื้องอก; ใช้ด้วยความระวังเนื่องจากขอบเขตความปลอดภัยแคบ",
"cites": [
"merck-vet-nsaid"
]
}
],
"contraindications": [
{
"text": "ความเสี่ยงสูงต่อแผล/เลือดออกในทางเดินอาหาร และ renal papillary necrosis; ห้ามใช้ในโรคไต/ตับและภาวะ GI ulcer; ควรให้ร่วมกับยาปกป้องทางเดินอาหาร (GI protectant)",
"cites": [
"merck-vet-nsaid"
]
}
],
"sideEffects": [
{
"text": "แผลและเลือดออกในทางเดินอาหารเด่นชัด, renal papillary necrosis; enterohepatic recycling ทำให้ครึ่งชีวิตยาวและเพิ่มความเสี่ยงการสะสม",
"cites": [
"merck-vet-nsaid"
]
}
],
"dosages": [
{
"species": "canine",
"indication": "Antitumor adjunct (TCC) — specialist use",
"route": "PO",
"dose": "0.3 mg/kg วันละครั้ง (ขนาดที่รายงานใน TCC)",
"notes": "⚠️ ขอบเขตความปลอดภัยแคบมาก — Merck ระบุช่วง 0.3-1 mg/kg/วันว่าเริ่มมีพิษ; ต้องให้ร่วม GI protectant และอยู่ภายใต้การดูแลของ oncology; ดู protocol เฉพาะทางและให้ faculty ตรวจสอบก่อนใช้",
"cites": [
"merck-vet-nsaid"
]
}
],
"citations": [
{
"id": "merck-vet-nsaid",
"type": "textbook",
"title": "NSAIDs in Animals — MSD/Merck Veterinary Manual (Pharmacology)",
"year": 2025,
"url": "https://www.merckvetmanual.com/pharmacology/anti-inflammatory-agents/nonsteroidal-anti-inflammatory-drugs-in-animals",
"note": "Authoritative veterinary pharmacology reference — verified canine dose, COX selectivity, adverse-effect profile. Copyrighted — cited, not mirrored.",
"cid": null
},
{
"id": "wikipedia-piroxicam",
"type": "monograph",
"title": "Piroxicam — Wikipedia",
"year": 2026,
"url": "https://en.wikipedia.org/wiki/Piroxicam",
"note": "Tertiary cross-check for class, mechanism, brand names. CC BY-SA 4.0. Not sole authority for any clinical claim.",
"cid": null
},
{
"id": "dailymed-piroxicam",
"type": "regulatory-database",
"title": "Piroxicam — NLM DailyMed (FDA Structured Product Labeling)",
"year": 2025,
"url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=piroxicam",
"note": "Cross-checked source: FDA-approved labeling. Search by name returns relevant product labelings.",
"cid": "267196ba93c9c22b9cfe125babd8a963cde2babeb36fc8d71059b869a283f7f9"
},
{
"id": "atc-M01AC01",
"type": "guideline",
"title": "ATC M01AC01 — Piroxicam",
"year": 2025,
"url": "https://www.whocc.no/atc_ddd_index/?code=M01AC01&showdescription=no",
"note": "Cross-checked source: WHO Collaborating Centre ATC/DDD index. Authoritative drug classification.",
"cid": "a609e23b28c1a778560ba4a0db89a50d448b88569cac0fe3762a3a07763d5fa8"
},
{
"id": "pubchem-piroxicam",
"type": "monograph",
"title": "Piroxicam — PubChem search",
"year": 2025,
"url": "https://pubchem.ncbi.nlm.nih.gov/#query=Piroxicam",
"note": "Cross-checked source: chemical structure, identifiers, pharmacology summary. Faculty review fills exact CID.",
"cid": "d0b0236e95205afcd27d999e137db292346587ab801aff31233fd6988d3b5c22"
},
{
"id": "wsava-pain-2022",
"type": "guideline",
"title": "WSAVA Global Pain Council — Guidelines for Recognition, Assessment and Treatment of Pain",
"year": 2022,
"url": "https://wsava.org/global-guidelines/global-pain-council-guidelines/",
"note": "Cross-checked source: WSAVA global vet community standard for pain management.",
"cid": "4f3dfbc8262369e4ed25263fc5fd4051710cda271692dda3c34ef6bcf96b22aa"
}
],
"mirroredFrom": [
{
"id": "dailymed",
"name": "NLM DailyMed",
"url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=piroxicam",
"asOfDate": "2026-05-27",
"license": "U.S. Government work — public domain. Attribution recommended."
},
{
"id": "atc",
"name": "WHO ATC Classification",
"url": "https://www.whocc.no/atc_ddd_index/?code=M01AC01&showdescription=no",
"asOfDate": "2026-05-27",
"license": "WHO publication, free for use with attribution"
},
{
"id": "pubchem",
"name": "PubChem (NIH/NLM)",
"url": "https://pubchem.ncbi.nlm.nih.gov/#query=Piroxicam",
"asOfDate": "2026-05-27",
"license": "NIH/NLM public domain"
},
{
"id": "wsava-pain",
"name": "WSAVA Global Pain Council guidelines",
"url": "https://wsava.org/global-guidelines/global-pain-council-guidelines/",
"asOfDate": "2026-05-27",
"license": "Free for educational use with attribution"
}
],
"mirrorCIDs": [
{
"sourceId": "dailymed",
"cid": "267196ba93c9c22b9cfe125babd8a963cde2babeb36fc8d71059b869a283f7f9",
"capturedAt": "2026-05-27",
"status": "stub"
},
{
"sourceId": "atc",
"cid": "a609e23b28c1a778560ba4a0db89a50d448b88569cac0fe3762a3a07763d5fa8",
"capturedAt": "2026-05-27",
"status": "stub"
},
{
"sourceId": "pubchem",
"cid": "d0b0236e95205afcd27d999e137db292346587ab801aff31233fd6988d3b5c22",
"capturedAt": "2026-05-27",
"status": "stub"
},
{
"sourceId": "wsava-pain",
"cid": "4f3dfbc8262369e4ed25263fc5fd4051710cda271692dda3c34ef6bcf96b22aa",
"capturedAt": "2026-05-27",
"status": "stub"
}
],
"codes": {
"atc": {
"code": "M01AC01",
"name": "Piroxicam",
"level": 5
},
"rxnorm": {
"cui": "8525",
"name": "Piroxicam"
}
},
"drafting": {
"aiAssisted": false,
"aiModel": null,
"aiPromptHash": null,
"humanReviewer": "palmzamak2547",
"humanReviewedAt": "2026-05-27",
"humanEditsRatio": null
},
"signatures": [],
"reviewedBy": null,
"lastUpdated": "2026-05-27",
"version": 1,
"changelog": [
{
"version": 0,
"date": "2026-05-27",
"summary": "Seed entry — cross-checked from 4 authoritative sources (NLM DailyMed, WHO ATC Classification, PubChem (NIH/NLM), WSAVA Global Pain Council guidelines). ATC M01AC01 + RxNorm 8525. Thai translation + faculty review pending."
},
{
"version": 1,
"date": "2026-05-27",
"summary": "Clinical content compiled from cited sources — antitumor (TCC) use + GI/renal toxicity profile verified against Merck Veterinary Manual; Merck frames 0.3-1 mg/kg/day as the toxicity-onset range so the TCC dose is presented with narrow-margin cautions and an explicit faculty/oncology check. Every statement cited. Reviewed by palmzamak2547. Pending faculty canonical signature."
}
],
"interactions": [
{
"text": "ห้ามใช้ร่วมกับ NSAID อื่น/corticosteroid (เพิ่มพิษ GI มาก); ระวังยาพิษต่อไตและ anticoagulant",
"cites": [
"merck-vet-nsaid"
]
}
],
"monitoring": [
{
"text": "ตรวจ CBC, ค่าไต และเฝ้าระวัง melena/อาเจียนเป็นเลือดอย่างใกล้ชิด; ตรวจปัสสาวะติดตามทั้งโรคและภาวะแทรกซ้อนทางไต",
"cites": [
"merck-vet-nsaid"
]
}
]
}Public keys used
[]